Inactive Instrument

Killer Waves Hawaii Inc Stock Other OTC

Equities

US4942361027

Food Processing

End-of-day quote Other OTC
- USD - Intraday chart for Killer Waves Hawaii Inc
Sales 2021 1.2M Sales 2022 658K Capitalization 270M
Net income 2021 -7M Net income 2022 -15M EV / Sales 2021 233 x
Net cash position 2021 24.08K Net Debt 2022 98.69K EV / Sales 2022 410 x
P/E ratio 2021
-32.5 x
P/E ratio 2022
-17 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 50.03%
More Fundamentals * Assessed data
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
More news
Managers TitleAgeSince
Chief Executive Officer 70 17-01-29
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 70 17-01-29
Corporate Officer/Principal - -
More insiders
Acro Biomedical Co., Ltd. is principally engaged in the business is the sale of cordyceps related products. The Company is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The Company's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus, which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The Company is involved in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. It sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
More about the company